ABALLI JOHN (President and CEO) sold 2.2% of their position (15.70K shares) of EXAGEN INC. on the open market
Open‑market sale worth $56.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/4/2026ACC: 0001843113-26-000004
DirectorOfficer· President and CEO
Since Mar 2026
-13.16K
Net shares
Net seller
$56.8K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
2.54K acquired · 15.70K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−15.70K
Price / share
$3.62
Trade value
$56.83K
% of position
2.2%
3/3/2026
703K→687.30K
Common Stock
Direct
Shares
+2.54K
Price / share
$3.08
Trade value
$7.80K
% of position
0.4%
3/3/2026
687.30K→689.83K
Total
Net shares
−13.16K
Net value
-$49.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/3/2026 | S · Sale | −15.70K | $3.62 | $56.83K | 2.2% | 703K | 687.30K |
| Common Stock Direct | 3/3/2026 | A · Award | +2.54K | $3.08 | $7.80K | 0.4% | 687.30K | 689.83K |
| Total | −13.16K | -$49.03K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned40.40K
Total
40.40K indirect40.40K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 40.40K | Indirect |
| Total | 40.40K | 40.40K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported